BACKGROUND: As unspecific antagonist of opiate receptor, naloxone is widely used for multiple diseases which are related with abnormal release of endogenous opium.
The results mentioned above indicate that the bradycardia effect of METmay be mediated by mu 2 subtype of opiate receptors instead of mu 1;